Prevent Future Fractures with Advanced Osteoporosis Infusions in Edgewater, MD

Osteoporosis infusions work by intervening in the body’s natural bone remodeling cycle. Under normal conditions, the body constantly removes old bone (resorption) and replaces it with new bone (formation). In osteoporosis, this balance is disrupted, and bone is removed faster than it can be replaced.

Most infusions, such as Zoledronic Acid (Reclast), belong to a class of drugs called bisphosphonates. These medications bind to the surfaces of the bones and inhibit the activity of osteoclasts—the cells responsible for breaking down bone tissue. By slowing down bone resorption, the infusions allow the bone-building cells (osteoblasts) to catch up, resulting in denser, more mineralized bone over time. Other infusions may act as biological markers that block specific proteins to prevent bone decay, effectively “shielding” the skeleton from thinning and making it significantly more resistant to breaks and compression fractures.

Not every patient with low bone density requires an infusion, but for many, it is the most effective clinical path. At Jean Walter Infusion Center, Dr. Nasser Nasseri, MD evaluates candidates based on several criteria:

• Patients with Malabsorption Issues: Individuals with Celiac disease, Crohn’s disease, or those who have had gastric bypass surgery often cannot absorb oral osteoporosis medications effectively.
• Intolerance to Oral Pills: Many patients experience severe heartburn, esophageal irritation, or stomach upset from oral bisphosphonates. Infusions bypass the digestive tract entirely.
• High Fracture Risk: Patients who have already suffered a “fragility fracture” or those with very low T-scores (below -2.5) are often prioritized for infusion therapy to ensure 100% medication adherence.
• Complexity of Schedule: For those who struggle to remember a daily or weekly pill—which often requires staying upright for 30–60 minutes and avoiding food—a once-yearly or twice-yearly infusion is a much more manageable option.

The transition from oral tablets to advanced infusions offers several clinical and lifestyle advantages. The most significant benefit is bioavailability. When you swallow a pill, only a small fraction of the medication actually reaches your bones; with an IV infusion, the full dose is delivered directly into the bloodstream.
Furthermore, infusions offer:

• Greater Potency: Medications like Reclast are highly effective at increasing bone mineral density in the hip and spine compared to some oral counterparts.
• Convenience: Instead of managing a strict weekly or monthly pill regimen, a single infusion session can provide protection for an entire year.
• Esophageal Safety: Oral medications carry a risk of irritating the esophagus if not taken perfectly. Infusions eliminate this risk, making them safer for patients with GERD or hiatal hernias.
• Verified Compliance: With pills, it is easy to miss a dose. With infusions performed at Jean Walter Infusion Center, both the patient and the doctor have the peace of mind knowing the treatment was successfully administered.

It is important to understand that bone health is a gradual physiological process. While the medication begins to inhabit the bone matrix and slow down bone loss within days of the infusion, measurable results take time to appear on diagnostic tests.

Most patients will see a stabilization or increase in bone density on a DEXA scan within 12 to 24 months of their first treatment. However, the clinical benefit—specifically the reduction in fracture risk—begins much sooner. Studies show that the risk of vertebral (spine) fractures can begin to decrease significantly within the first year of starting infusion therapy. To ensure the treatment is working, we perform routine follow-ups to monitor bone turnover markers in the blood, which can provide an early indication that the medication is successfully slowing down bone resorption.

Dr. Nasser Nasseri, MD is a specialist dedicated to the intersection of rheumatology and metabolic bone health. At Jean Walter Infusion Center, he utilizes a patient-centric model that prioritizes safety, comfort, and clinical results. By focusing on advanced osteoporosis infusions, Dr. Nasseri provides a high-level alternative for patients who require more intensive bone density management than standard primary care can offer. Our Edgewater facility is designed to provide a streamlined, boutique experience where patients receive one-on-one attention from an expert team. Nasseri’s commitment to staying at the forefront of bone-strengthening technology ensures that every patient receives a personalized care plan designed to protect their mobility, reduce their pain, and prevent future fractures that can limit independence.

Take control of your skeletal health before a fracture occurs. Visit Jean Walter Infusion Center for osteoporosis infusions in Edgewater, MD, and let us help you maintain your strength and vitality for years to come. For more information, contact us or book an appointment online. We are conveniently located at 3168 Braverton St., Suite 330A, Edgewater, MD 21037. We serve patients from Edgewater MD, Riva MD, Davidsonville MD, Annapolis MD, and surrounding areas.